News | Angiography | April 27, 2017

New Hampshire Hospital Expands Vascular Care with Toshiba Medical's Infinix-I Sky +

Angiography system offers flexibility, speed and 3-D imaging to simplify complex vascular exams

New Hampshire Hospital Expands Vascular Care with Toshiba Medical's Infinix-I Sky +

April 27, 2017 — Wentworth-Douglass Hospital in Dover, N.H., installed Toshiba Medical’s Infinix-i Sky + angiography system in its endovascular hybrid operating room (OR). Wentworth-Douglass is using the system to diagnose and treat a wide range of vascular disorders, such as aneurysms and peripheral vascular disease. 

“We needed an angiography system that would work seamlessly with our existing OR table while offering high-quality imaging, workflow features and the flexibility to perform any vascular procedure needed. The Infinix-i Sky + meets all of these needs,” said James Estes, M.D., director, Vascular Surgery Services for Wentworth Health Partners Cardiovascular Group at Wentworth-Douglass Hospital. “We knew Toshiba Medical would be a good partner and will ensure our success throughout the life of the system, including service and ongoing training.”

The Infinix-i Sky + ceiling-mounted system features a double sliding C-arm that allows the C-arm to be positioned in more ways to help doctors increase coverage, speed and patient access. The system’s 12 x 16-inch flat panel can be positioned above or below the patient, offering physicians increased flexibility for procedures that require additional space, and its low-contrast imaging capabilities enable superior visualization. The system also incorporates an extensive set of innovative dose management tools, designed to help clinicians in the practice of ALARA (As Low As Reasonably Achievable). This includes technology like the Dose Tracking System that estimates peak skin dose exposure in real time.

For more information: www.medical.toshiba.com

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
Virtual Phantoms Inc. Releases VirtualDose-IR
Technology | Radiation Dose Management| August 07, 2017
Virtual Phantoms Inc. announced the release of VirtualDoseIR, a tool for assessing organ dose from interventional...
Overlay Init